Tirzepatide has already been approved by the FDA for the management of chronic weight in adults who are either obese or overweight and have at least one condition related to weight
That is happening because the patient population eligible for this medication is so large
If you're currently exploring medical weight loss options, the treatments available today, including GLP-1 medications like semaglutide and tirzepatide, already offer meaningful, evidence-based results
264,269 Furthermore, GLP-1 can slow down gastric emptying by activating the vagus nerve, a part of the autonomic nervous system crucial for regulating the activities of the gastrointestinal tract
It's a lazy metric
If your goal is gut-lining strength, inflammation control, or metabolic resilience, Akkermansia is the bacteria to understand first